EUVIMEDEUVIMED entdecken
Crossref

Medicare’s Historic Prescription Drug Price Negotiations

Lawrence O Gostin, James G Hodge, Andrew J Twinamatsiko

JAMA · 2023

DOI: 10.1001/jama.2023.19506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Lawrence O Gostin und 2 weiteren Autor:innen. Beteiligte Einrichtung: O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC. Hauptthemen laut MEDLINE: Drug Costs, Medicare, Prescription Drugs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint evaluates the legal claims and policy implications of historic drug price negotiations possible with the Inflation Reduction Act of 2022.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CostsMedicarePrescription DrugsNegotiatingPrescriptionsUnited States

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC.
  • Center for Public Health Law and Policy, ASU Sandra Day O'Connor College of Law, Phoenix, Arizona.

Zitieren

APA

Gostin, L. O., Hodge, J. G., & Twinamatsiko, A. J. (2023). Medicare’s Historic Prescription Drug Price Negotiations. JAMA. https://doi.org/10.1001/jama.2023.19506

Vancouver

Gostin LO, Hodge JG, Twinamatsiko AJ. Medicare’s Historic Prescription Drug Price Negotiations. JAMA. 2023. doi:10.1001/jama.2023.19506

BibTeX
@article{Gostin2023,
  author = {Gostin, Lawrence O and Hodge, James G and Twinamatsiko, Andrew J},
  title = {Medicare’s Historic Prescription Drug Price Negotiations},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.19506}
}
Kostenlos starten →